Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;19(7):2020-2028.
doi: 10.1111/ajt.15250. Epub 2019 Jan 25.

Survival benefit of accepting livers from deceased donors over 70 years old

Affiliations

Survival benefit of accepting livers from deceased donors over 70 years old

Christine E Haugen et al. Am J Transplant. 2019 Jul.

Abstract

Livers from older donors (OLDs; age ≥70) are risky and often declined; however, it is likely that some candidates will benefit from OLDs versus waiting for younger ones. To characterize the survival benefit of accepting OLD grafts, we used 2009-2017 SRTR data to identify 24 431 adult liver transplant (LT) candidates who were offered OLD grafts eventually accepted by someone. Outcomes from the time-of-offer were compared between candidates who accepted an OLD graft and matched controls within MELD ± 2 who declined the same offer. Candidates who accepted OLD grafts (n = 1311) were older (60.5 vs. 57.8 years, P < .001), had a higher median MELD score (25 vs. 22, P < .001), and were less likely to have hepatitis C cirrhosis (14.9% vs. 31.2%, P < .001). Five-year cumulative mortality among those who accepted versus declined the same OLD offer was 23.4% versus 41.2% (P < .001). Candidates who accepted OLDs experienced an almost twofold reduction in mortality (aHR:0.45 0.520.59 , P < .001) compared to those who declined the same offer, especially among the highest MELD (35-40) candidates (aHR:0.10 0.240.55 , P = .001). Accepting an OLD offer provided substantial long-term survival benefit compared to waiting for a better organ offer, notably among candidates with MELD 35-40. Providers should consider these benefits as they evaluate OLD graft offers.

Keywords: Scientific Registry for Transplant Recipients (SRTR); clinical research/practice; donors and donation: deceased; donors and donation: extended criteria; liver transplantation/hepatology; organ acceptance.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Outcomes among candidates who ever declined an older liver donor (OLD) graft between 12/28/2009–1/6/2017 (n= 23,709) stratified by allocation MELD at the time of first OLD decline. Candidates were followed forward from the date of initial OLD graft decline.
Five-year cumulative incidence is reported for each potential outcome in figure. OLD = older liver donor, DDLT= deceased donor liver transplant, *Reasons for removal from waitlist included declined transplant, transplanted at another center or in another country, candidate condition improved, living donor liver transplant, unable to contact candidate, and other
Figure 2:
Figure 2:. Cumulative mortality after OLD offer acceptance and decline among candidates with (A) MELD 15–22, (B) MELD 23–28, (C) MELD 29–34, and (D) MELD 35–40 at time of offer.
Candidates matched on the liver offered and MELD score (within 2 points) at time of offer. Cumulative mortality post-decision to decline OLD offer includes candidates who subsequently underwent living donor LT, underwent younger donor deceased donor LT, were removed from the waitlist, and those who remained on the waitlist.

Comment in

References

    1. Burra P, Chirizzi L, Cardin R, Cadrobbi R, Baldan N, Calabrese F et al. Warm hepatic ischemia in pigs: effects of L-arginine and oligotide treatment. J Invest Surg 2001;14(6):303–312. - PubMed
    1. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB et al. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant 2017;17 Suppl 1:174–251. - PubMed
    1. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology 2012;143(5):1261–1265. - PMC - PubMed
    1. Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible Donors as a Strategy to Decrease the Organ Shortage. Am J Transplant 2016. - PubMed
    1. Halazun KJ, Rana AA, Fortune B, Quillin RC 3rd, Verna EC, Samstein B et al. No country for old livers? Examining and optimizing the utilization of elderly liver grafts. Am J Transplant 2017. - PubMed

Publication types